Funder
University of Ottawa Clinical Research Chair Award
Children’s Hospital of Eastern Ontario Research Institute
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference18 articles.
1. Ward LM, Bardai G, Moffatt P, Al-Jallad H, Trejo P, Glorieux FH, Rauch F (2016) Osteogenesis imperfecta type VI in individuals from Northern Canada. Calcif Tissue Int 98(6):566–572. https://doi.org/10.1007/s00223-016-0110-1
2. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17(1):30–38. https://doi.org/10.1359/jbmr.2002.17.1.30
3. Trejo P, Palomo T, Montpetit K, Fassier F, Sato A, Glorieux FH, Rauch F (2017) Long-term follow-up in osteogenesis imperfecta type VI. Osteoporos Int 28(10):2975–2983. https://doi.org/10.1007/s00198-017-4141-x
4. Baron R, Ferrari S, Russell RGG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48(4):677–692. https://doi.org/10.1016/j.bone.2010.11.020
5. Trejo P, Rauch F, Ward LM (2018) Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact 18(1):76–80
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献